Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation

NCT04499729 | Terminated DMC

• 1 other identifier: R44MH114725
• Study Type: interventional
• Target: 318
• Locations: 1 country
• Sites: 1

Brief Summary

The overarching aim of the proposed project is to conduct a pragmatic, quality improvement evaluation of the IntelliCare Platform for improving processes of care in the Rush Collaborative Care program, and improving patient population depression outcomes, to determine the long-term utility of IntelliCare for Rush.

Conditions

Depression

Outcome Measures

Primary Outcomes (2)

• Depression

  Patient Health Questionnaire-9 (PHQ-9) assessment for depression

  Up to 20 Months

• Number of assessments

  Number of Patient Health Questionnaire (PHQ-9) assessments acquired in the EHR

  Up to 20 Months

Secondary Outcomes (1)

• First to last assessment

  Up to 20 Months

Study Arms (2)

Treatment as Usual (TAU)

ACTIVE COMPARATOR

TAU will be the treatment that is provided through the Rush Collaborative Care program as part of their service

Behavioral: Treatment as Usual (TAU)

IntelliCare

EXPERIMENTAL

Patients will be offered IntelliCare as part of their care in the Rush Collaborative Care service. Patients who agree will download the IntelliCare app, which provides self management and collects symptom self-report data. Symptom severity scores are displayed to the care manager, allowing them to manage the patient's care. The app also provides a secure messaging service for communication between the care manager and the patient.

Device: IntelliCare

Interventions

IntelliCare DEVICE

IntelliCare provides self management and collects symptom self-report data. Symptom severity scores are displayed to the care manager, allowing them to manage the patient's care. The app also provides a secure messaging service for communication between the care manager and the patient.

IntelliCare

Treatment as Usual (TAU) BEHAVIORAL

Treatment as usual in the Rush Collaborative Care service

Treatment as Usual (TAU)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Enrolled in Rush Collaborative Care service
• Owns a personal smartphone

You may not qualify if:

• None

Sponsors & Collaborators

• Adaptive Health, Inc: lead
• Rush University Medical Center: collaborator

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Depression

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior

Study Officials

• Carolyn MacIver

  Adaptive Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Model Details: We will utilize a pragmatic, system-wide rollout quality improvement evaluation design. Data from patients in the Rush Collaborative Care service will be used beginning Dec 1, 2019. The first care manager will begin offering IntelliCare as part of the collaborative care service in September, 2020, and one additional care manager will begin offering IntelliCare to patients every 3 months

Study Record Dates

• First Submitted: July 27, 2020
• First Posted: August 5, 2020
• Study Start: December 1, 2019
• Primary Completion: May 1, 2021
• Study Completion: May 1, 2021
• Last Updated: December 3, 2021

Record last verified: 2021-11

Locations

US (1)